Health and Biosciences
Kevin represents emerging and established companies in the health, diagnostics and biosciences sector with products that lack a clear pathway to Medicare and Medicaid coverage or favorable reimbursement. He works with companies facing regulatory obstacles with the Food and Drug Administration (FDA) or seeking to engage with Congress and federal agencies, including:
- Centers for Medicare and Medicaid Services (CMS)
- Centers for Disease Control and Prevention (CDC)
- Health Resources and Services Administration (HRSA)
- Agency for Healthcare Research & Quality (ARHQ)
Kevin leverages public health initiatives to ensure patient access to appropriate medical therapies, devices and molecular diagnostic products. He also partners with stakeholders to promote affordable, quality health care services and therapies; fund research and public health programs; and ensure reimbursement for hospital and provider services.
Appropriations and Health Care Initiatives
Kevin served as U.S. Rep. Rosa DeLauro’s (D-CT) chief of staff during her tenure as Chair of the House Appropriations Subcommittee on Agriculture and FDA and a senior member of the Labor Health and Human Services Subcommittee. He assisted Chairwoman DeLauro in advancing her appropriations priorities and on a range of legislation related to health care, food safety and labeling, public health and women's health care.
Arthritis Foundation Patient Advocacy
As senior vice president of public policy and advocacy for the Arthritis Foundation, Kevin built an influential, 50-state grassroots advocacy network and achieved a number of advocacy victories, including a provision on juvenile arthritis and pediatric rheumatology in the Children's Health Act and a Medicare demonstration project on self-injectable biologic therapies.
Amgen Initiatives on Patient Access to Self-Injectable Therapies
As director of strategic advocacy and alliance development in Amgen's D.C. global government affairs office, Kevin led a team that focused on initiatives to improve Medicare beneficiary coverage for biologic therapies.
Rep. Rosa DeLauro (D-CT), Chief of Staff
- Rep. Sherrod Brown (D-OH), Legislative Director
- Rep. Tom Foglietta (D-PA), Press Secretary and Legislative Assistant
Kevin is a consulting professional within Faegre Baker Daniels Consulting, and does not act as a lawyer for clients. Learn more about the Faegre Baker Daniels Consulting practice.